(Q40244679)

18 September 2017

title

Synthesis and biological evaluation of boronic acid containing cis-stilbenes as apoptotic tubulin polymerization inhibitors (English)

1 reference

18 September 2017

0 references

1

1 reference

18 September 2017

Hirokazu Kuroda

2

1 reference

18 September 2017

Hiroyuki Saito

3

1 reference

18 September 2017

Ryo Suzuki

4

1 reference

18 September 2017

Takao Yamori

5

1 reference

18 September 2017

Kazuo Maruyama

6

1 reference

18 September 2017

Tatsuya Haga

7

1 reference

18 September 2017

publication date

1 July 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

1

1 reference

18 September 2017

issue

7

1 reference

18 September 2017

page(s)

729-740

1 reference

Anti-tumor efficacy of paclitaxel against human lung cancer xenografts.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

Isolation, structure, and synthesis of combretastatin A-2, A-3, and B-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Antimitotic natural products and their interactions with tubulin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Structure of the alpha beta tubulin dimer by electron crystallography

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Identification of cysteine 354 of beta-tubulin as part of the binding site for the A ring of colchicine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Localization of the colchicine-binding site of tubulin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a)

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Combination effect of AC-7700, a novel combretastatin A-4 derivative, and cisplatin against murine and human tumors in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Synthesis and evaluation of analogs of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Syntheses and antitumor activity of cis-restricted combretastatins: 5-membered heterocyclic analogues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Synthesis and pharmacological activity of diarylindole derivatives. Cytotoxic agents based on combretastatins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Potent, orally active heterocycle-based combretastatin A-4 analogues: synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Antineoplastic agents. 379. Synthesis of phenstatin phosphate

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Structure-activity and crystallographic analysis of benzophenone derivatives-the potential anticancer agents.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Boronic acid compounds as potential pharmaceutical agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

2-phenylethaneboronic acid, a possible transition-state analog for chymotrypsin

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Episelection: novel Ki approximately nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Potentially Macrocyclic Peptidyl Boronic Acids as Chymotrypsin Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Protease inhibitors: current status and future prospects

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Design, synthesis, and biological evaluation of aminoboronic acids as growth-factor receptor inhibitors of EGFR and VEGFR-1 tyrosine kinases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Novel syntheses of cis and trans isomers of combretastatin A-4.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

An improved protocol for the preparation of 3-pyridyl- and some arylboronic acids

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Microtubule Assembly in the Absence of Added Nucleotides

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Polymerization and depolymerization of microtubules in vitro as studied by flow birefringence

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Interpretation of the light scattering from long rods.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Synthesis, Anticancer Activity, and Inhibition of Tubulin Polymerization by Conformationally Restricted Analogues of Lavendustin A

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600068

7 January 2021

Identifiers

DOI

10.1002/CMDC.200600068

1 reference

18 September 2017

1 reference